Xenon Pharmaceuticals Inc (XENE)
R&D Expense Growth
43.04%
Fiscal year · Period ending:
XENE R&D Expense Growth
Latest reported43.04%period ending
Latest reported43.04%period ending
XENE FY R&D Growth (YoY) (0.00% → 43.04%)
Latest values, visible window
High-resolution chart · PNG
XENE r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 43.0354% | |
| 25.5994% | |
| 58.3783% | |
| 40.1574% | |
| 49.3637% | |
| 30.0631% | |
| 64.3607% | |
| -7.5822% | |
| 28.9742% | |
| 30.8606% | |
| 28.7559% | |
| -4.3485% | |
| 17.6758% | |
| -15.0138% | |
| 0% |